Solvay Feedback conference call
Below are the highlights from the conference call. FY23 uEBITDA was roughly flat organically at 1246m which represents a minor miss (-0.6%) vs CSS, due to a lower than expected (and often lumpy) Corporate Costs line. FY24 uEBITDA guidance calls for a 10-20% organic decline vs the restated 2023 base, with consensus roughly at the midpoint of the € 925-1040m range (and KBCS close to the high end of the range). After the recent spun off of Syensqo, Solvay is a base chemicals group with leading market and technology positions in the vast majority of its businesses. The company will be managed with a conservative financial approach, favouring dividends over aggressive growth and starting from a solid balance sheet (1.2x leverage). The stable to growing dividend flow implies a dividend yield of almost 10% on FY23 dividend. Other valuation ratios also look very attractive and prompt us to reiterate our BUY rating.Solvay is engaged in chemical and plastic businesses worldwide. Co. offers chemical products such as advanced materials, barium strontium, calcium chloride, caustic soda, chlorinated products, fluor, peroxygen products, polyglycerols, precipitated calcium carbonate, soda ash, and sodium bicarbonate. It also provides specialty polymers, such as Spire ultra polymers, Solviva biomaterials, and sulfone polymers. Co. structures its activities around five operating segments: Advanced Formulations, Advanced Materials, Performance Chemicals, Functional Polymers and Corporate & Business Services, each with its own specific business model and each comprised of Global Business Units (GBUs).
We are a financial services provider for several types of professional clients, each with distinct needs.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.